Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

951 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology.
El Hassouni B, Mantini G, Li Petri G, Capula M, Boyd L, Weinstein HNW, Vallés-Marti A, Kouwenhoven MCM, Giovannetti E, Westerman BA, Peters GJ; EORTC PAMM Group. El Hassouni B, et al. Among authors: boyd l. Anticancer Res. 2019 Jul;39(7):3303-3309. doi: 10.21873/anticanres.13472. Anticancer Res. 2019. PMID: 31262850 Review.
Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach.
Le Large TYS, Meijer LL, Paleckyte R, Boyd LNC, Kok B, Wurdinger T, Schelfhorst T, Piersma SR, Pham TV, van Grieken NCT, Zonderhuis BM, Daams F, van Laarhoven HWM, Bijlsma MF, Jimenez CR, Giovannetti E, Kazemier G. Le Large TYS, et al. Among authors: boyd lnc. Oncologist. 2020 Apr;25(4):e634-e643. doi: 10.1634/theoncologist.2019-0680. Epub 2020 Jan 14. Oncologist. 2020. PMID: 31943574 Free PMC article.
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach.
Boyd LNC, Ali M, Kam L, Puik JR, Rodrigues SMF, Zwart ES, Daams F, Zonderhuis BM, Meijer LL, Le Large TYS, Giovannetti E, van Laarhoven HWM, Kazemier G. Boyd LNC, et al. Cancers (Basel). 2022 Jan 11;14(2):344. doi: 10.3390/cancers14020344. Cancers (Basel). 2022. PMID: 35053506 Free PMC article.
hENT1 as a Predictive Biomarker in PDAC-Letter.
Boyd LNC, Ali M, Puik JR, Meijer LL, Le Large TYS, van Laarhoven HWM, Giovannetti E, Kazemier G. Boyd LNC, et al. Clin Cancer Res. 2023 Aug 1;29(15):2944. doi: 10.1158/1078-0432.CCR-22-3827. Clin Cancer Res. 2023. PMID: 37525961 No abstract available.
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.
Boyd LNC, Ali M, Comandatore A, Garajova I, Kam L, Puik JR, Fraga Rodrigues SM, Meijer LL, Le Large TYS, Besselink MG, Morelli L, Frampton A, van Laarhoven HWM, Giovannetti E, Kazemier G. Boyd LNC, et al. JAMA Netw Open. 2023 Aug 1;6(8):e2331197. doi: 10.1001/jamanetworkopen.2023.31197. JAMA Netw Open. 2023. PMID: 37639271 Free PMC article.
951 results